Compounds > urea

urea and indinavir sulfate

urea has been researched along with indinavir sulfate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alam, M; Bechtold, CM; Colonno, RJ; Gong, YF; Greytok, JA; Lin, PF; Robinson, BS; Rose, RE; Terry, BJ1
Bold, G; Capraro, HG; Goutte, G; Klimkait, T; Lazdins, JK; Mestan, J; Walker, MR1
Aungst, BJ; Bulgarelli, JP; Nguyen, NH; Oates-Lenz, K1
Boross, PI; Harrison, RW; Louis, JM; Mahalingam, B; Tozser, J; Wang, YF; Weber, IT1
Frushicheva, MP; Singh, N; Warshel, A1

Other Studies

6 other study(ies) available for urea and indinavir sulfate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Feb-20, Volume: 93, Issue:4

    Topics: Amino Acid Sequence; Carbamates; Clone Cells; DNA Mutational Analysis; DNA, Recombinant; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethanolamines; HeLa Cells; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Methylurea Compounds; Molecular Sequence Data; Point Mutation; Proviruses; Pyridines; Quinolines; Reassortant Viruses; Recombinant Fusion Proteins; Saquinavir; T-Lymphocytes; Urea; Valine

1996
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors.
    The Journal of infectious diseases, 1997, Volume: 175, Issue:5

    Topics: Anti-HIV Agents; Carbamates; Cell Line; Cells, Cultured; Ethylenes; Furans; HIV Protease Inhibitors; HIV Seronegativity; HIV-1; Humans; Indinavir; Kinetics; Lymphocytes; Orosomucoid; Ritonavir; Saquinavir; Sulfonamides; Urea; Virus Replication

1997
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds.
    Pharmaceutical research, 2000, Volume: 17, Issue:10

    Topics: Acetamides; Albumins; Azepines; Caco-2 Cells; Carbamates; Cell Membrane Permeability; Furans; HIV Protease Inhibitors; Humans; Indinavir; Intestinal Absorption; Nelfinavir; Ritonavir; Solvents; Structure-Activity Relationship; Sulfonamides; Urea

2000
Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site.
    European journal of biochemistry, 2004, Volume: 271, Issue:8

    Topics: Amino Acid Substitution; Amino Acids; Binding Sites; Crystallography, X-Ray; Escherichia coli; HIV Protease; HIV Protease Inhibitors; Hydrogen Bonding; Indinavir; Kinetics; Models, Molecular; Oligopeptides; Protein Conformation; Recombinant Proteins; Thermodynamics; Urea

2004
Validating the vitality strategy for fighting drug resistance.
    Proteins, 2012, Volume: 80, Issue:4

    Topics: Antiviral Agents; Azepines; Carrier Proteins; Catalytic Domain; Computational Biology; Computer Simulation; Databases, Factual; Drug Resistance, Viral; Enzyme Activation; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Ligands; Molecular Structure; Static Electricity; Thermodynamics; Urea

2012